$Hims & Hers Health(HIMS.US) barely moved, $Tempus AI(TEM.US) rose slightly. Hims' member repurchase and new category expansion are still in the ramp-up phase, and it will take time for Tempus's AI diagnostic data to convert into revenue. The story is compelling, but there's still a gap before performance validation. In this catalyst-deficient stage, we're just waiting it out 🤔
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
